^
Association details:
| Biomarker: | ACSL4 overexpression |
|---|---|
| Cancer: | Cutaneous Melanoma |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
High expression of ferroptosis-sensitizer ACSL4 as an indicator of good response to immune checkpoint inhibitors and preferable survival with increased TIICs in skin cutaneous melanoma
Published date:
05/19/2021
Excerpt:
Favorable OS was observed in the patients with high ACSL4 expression...High ACSL4 expression maybe indicates a good response to ICIs and long survival in SKCM.
DOI:
10.1200/JCO.2021.39.15_suppl.e21594
